Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program

J Gastrointest Cancer. 2024 Sep;55(3):1460-1462. doi: 10.1007/s12029-024-01041-7. Epub 2024 May 20.

Authors

Kanika Malani¹, Yousef Elfanagely², Kittichai Promrat^{2

3}

Affiliations

¹ The Warren Alpert Medical School, Brown University, 195 Waterman Street, Providence, RI, 02906, USA. kanika_malani@brown.edu.
² Division of Gastroenterology, Brown University, Providence, RI, USA.
³ Section of Gastroenterology, Providence Veterans Affairs Medical Center, Providence, RI, USA.

PMID: 38764007
DOI: 10.1007/s12029-024-01041-7

No abstract available

MeSH terms

Aged
COVID-19* / diagnosis
COVID-19* / epidemiology
COVID-19* / prevention & control
COVID-19* / virology
Colorectal Neoplasms* / diagnosis
Early Detection of Cancer* / methods
Feces / chemistry
Feces / virology
Female
Humans
Male
Mass Screening / methods
Middle Aged
Occult Blood*
SARS-CoV-2*